Donating a kidney may make it difficult to change or initiate life and health insurance

July 16, 2014

People who selflessly step up and donate a kidney can face insurance challenges afterwards, despite the lack of evidence that they have increased health risks. The finding, which comes from a new study published in the American Journal of Transplantation, suggests that actions by insurers may create unnecessary burden and stress for those choosing to donate and could negatively impact the likelihood of live kidney donation.

The impact of kidney donation on the ability to change or initiate health or life insurance following donation is unknown. To investigate, Dorry Segev, MD, PhD, of the Johns Hopkins University School of Public Health, and his colleagues surveyed 1046 individuals who donated a kidney at their center between 1970 and 2011. Participants were asked whether they changed or initiated health or life insurance after donation, and if they had any difficulty doing so.

Among 395 donors who changed or initiated after donation, 27 (7 percent) reported difficulty. Among those who reported difficulty, 15 were denied altogether, 12 were charged a higher premium, and eight were told they had a pre-existing condition because they were .

Among 186 donors who changed or initiated life insurance after donation, 46 (25 percent) reported difficulty. Among those who reported difficulty, 23 were denied altogether, 27 were charged a higher premium, and 17 were told they had a preexisting condition because they were kidney donors.

The results suggest that a high proportion of kidney donors may have difficulty changing or initiating insurance, particularly . The findings also highlight the serious problems related to coverage in the nation's fragmented health insurance system even though, as stated in the Patient Protection and Affordable Care Act, insurance companies can no longer refuse health insurance to live kidney donors or charge them a higher insurance rate.

"Kidney donors are among the healthiest individuals in the population. It's such a shame that some insurance companies are giving donors a hard time, often because of a misinterpretation that the normal biological changes that occur after donation are an indication of ," said Dr. Segev. "This is a reminder that we need to remain strong advocates for our donors, and they need to remain strong advocates for themselves, educating when these situations arise."

Explore further: Study finds kidney donation safe for healthy older adults

More information: "Difficulty Obtaining Insurance After Live Kidney Donation." Brian J. Boyarsky, Allan B. Massie PhD, Jennifer Alejo, Kyle J. Van Arendonk, Spencer Wildonger, Jacqueline M. Garonzik- Wang, Robert A. Montgomery, Neha A. Deshpande, Abimereki D. Muzaale, and Dorry L. Segev. American Journal of Transplantation; Published Online: July 16, 2014 (DOI: 10.1111/ajt.12819).

Related Stories

Study finds kidney donation safe for healthy older adults

July 9, 2014
Older kidney donors enjoy similar longevity and cardiovascular health as other healthy mature individuals, according to a new study published in the American Journal of Transplantation. The findings may provide some reassurance ...

Kidney failure risk for organ donors 'extremely low'

February 11, 2014
The risk of a kidney donor developing kidney failure in the remaining organ is much lower than in the population at large, even when compared with people who have two kidneys, according to results of new Johns Hopkins research.

Never too old to donate a kidney?

October 28, 2011
People over age 70 years of age can safely donate a kidney, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results provide good news for patients ...

Dollars for donors: Many support financial incentives to encourage organ donation

September 27, 2012
Most Canadians view financial incentives for deceased kidney donation to be acceptable, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). Nearly half ...

Transplantation issues: Kidney donors and children in need of transplants

November 2, 2012
Three studies presented during the American Society of Nephrology's Annual Kidney Week provide new information related to kidney transplantation—specifically, the post-transplant health of kidney donors and the racial disparities ...

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.